Sign up to save your podcasts
Or
Share Does finding a rare mutation accomplish anything?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Does finding a rare mutation accomplish anything?
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
View all episodes
By Illumina, Inc.
4.7
6767 ratings
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
More shows like Illumina Genomics Podcast
View all
Science Friday
6,069 Listeners
Nature Podcast
765 Listeners
Science Magazine Podcast
806 Listeners
Planet Money
30,856 Listeners
This Week in Virology
2,042 Listeners
Freakonomics Radio
31,913 Listeners
Hidden Brain
43,387 Listeners
This Week in Virology
224 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Indicator from Planet Money
9,529 Listeners
The Readout Loud
319 Listeners
The Peter Attia Drive
7,777 Listeners
Short Wave
6,240 Listeners
Dwarkesh Podcast
350 Listeners
Behind the Genes
4 Listeners